7 completed. 7 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 7 |
Follow Candidiasis, Oral: new trials by email Literature Review of Candidiasis, Oral trials Research Report on Candidiasis, Oral
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic Propolis, Miconazole - Candidiasis, Oral, Stomatitis, Denture | Phase 3 | Completed | University of Sao Paulo | 40 | 2016-01-01 | 2016-06-30 |
| Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis micafungin, caspofungin - Candidiasis, Oral | Phase 3 | Completed | Astellas Pharma Inc | 454 | 2004-06-01 | 2014-08-20 |
| Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis Micafungin, Fluconazole - Candidiasis, Oral | Phase 3 | Completed | Astellas Pharma Inc | 523 | 2003-08-01 | 2014-09-18 |
| A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal Candidiasis Gentian violet 1% solution, Gentian violet 0.00165% solution, Nystatin solution - Candidiasis, Oral | Phase 3 | Completed | Kamuzu University of Health Sciences | 558 | 2002-11-01 | 2008-02-11 |
| Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis Roxanes's clotrimazole troches, Mycelex® troches - Candidiasis, Oral | Phase 3 | Completed | Boehringer Ingelheim | 187 | 2001-05-01 | 2014-07-14 |
| A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2 Nystatin - Candidiasis, Oral, Gastrointestinal Diseases | Phase 3 | Completed | National Cancer Institute (NCI) | 84 | 1999-04-01 | 2008-03-04 |
| Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients Posaconazole, Fluconazole - Candidiasis, Oral, HIV Infections | Phase 3 | Completed | Schering-Plough | 300 | 1998-08-01 | 2005-06-24 |
AIDS-Related Opportunistic Infections (1) · Gastrointestinal Diseases (1) · HIV Infections (1) · Mucositis (1) · Pharyngeal Diseases (1) · Stomatitis (1) · Stomatitis, Denture (1)
Bacterial Infections and Mycoses (7) · Candidiasis (7) · Infections (7) · Mouth Diseases (7) · Mycoses (7) · Stomatognathic Diseases (7) · Blood-Borne Infections (1) · Communicable Diseases (1) · Digestive System Diseases (1) · Gastroenteritis (1) · Genital Diseases (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Lentivirus Infections (1) · Opportunistic Infections (1)
Fluconazole (2) · Micafungin (2) · Caspofungin (1) · Gentian Violet (1) · Miconazole (1) · Nystatin (1) · Propolis (1) · Solutions (1) · posaconazole (1)
Astellas Pharma Inc (2) · Boehringer Ingelheim (1) · Kamuzu University of Health Sciences (1) · National Cancer Institute (NCI) (1) · Schering-Plough (1) · University of Sao Paulo (1)
Brazil (3) · Peru (2) · South Africa (2) · United States (2) · Argentina (1) · Barbados (1) · Malawi (1)
ELizabeth M Molyneux, FRCPCH FFAEM (1) · Erica N Lia, PhD (1) · Gisela M Pina, DDS (1)